Clear Labs Inc

Clear Labs Inc specializes in advanced genomic sequencing and diagnostic automation. Their core capabilities include Whole Genome Sequencing (WGS) and the provision of specialized reagents and consumables for pathogen detection, specifically targeting SARS-CoV-2. The company provides integrated technical solutions through their Clear Dx platform, offering automation bundles, system upgrades, and ongoing service agreements to support high-complexity laboratory operations. The company maintains a strong relationship with the Department of Health and the Indiana Department of Health. Their work for these agencies focuses on the delivery of sequencing services, the implementation of diagnostic automation hardware, and the execution of long-term service agreements to ensure operational continuity of laboratory equipment. Clear Labs Inc is positioned within the public health and biotechnology vertical, focusing on the intersection of genomic surveillance and automated diagnostic workflows. Their market positioning centers on providing the critical infrastructure and consumables necessary for state and federal health departments to conduct large-scale viral sequencing and monitoring. Based in San Carlos, California, Clear Labs Inc operates as a specialized provider of laboratory technology and services to the government health sector.